Tenax Therapeutics (TENX) Change in Cash (2010 - 2026)
Tenax Therapeutics (TENX) posted quarterly Change in Cash of -$779000.0 for Q2 2026, up 86.98% year-over-year from -$416612.9 in Q2 2025, and down 103.68% on a QoQ basis from $21.2 million in Q1 2026.
Tenax Therapeutics (TENX) Change in Cash (2010 - 2026) Analysis & Trends
Tenax Therapeutics has reported Change in Cash for 17 years, with the latest figure at -$779000.0 in Q2 2026.
- Change in Cash for Q2 2026 came in at -$779000.0, up 86.98% year-over-year; the trailing twelve-month figure through Jun 2026 was $12.5 million (down 86.98% YoY), and the FY2025 annual result was $2.7 million, down 96.81% from the prior year.
- Change in Cash slipped to -$779000.0 in Q2 2026, from $21.2 million in the prior quarter.
- Over five years, Change in Cash peaked at $88.9 million in Q3 2024 and troughed at -$6.1 million in Q3 2025.
- A 5-year average of $6.2 million and a median of -$1.5 million in 2022 frame the typical range for Change in Cash.
- The largest YoY upside for Change in Cash was 4048.03% in 2024 against a maximum downside of 209.91% in 2024.
- A 5-year view of Change in Cash shows it stood at -$1.7 million in 2022, then rose by 19.81% to -$1.3 million in 2023, then slumped by 156.4% to -$3.5 million in 2024, then jumped by 47.86% to -$1.8 million in 2025, then surged by 56.82% to -$779000.0 in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were -$779000.0 in Q2 2026, $21.2 million in Q1 2026, and -$1.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -185.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 427.25 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.94 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -37.42 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 225.59 Mn |
| 10 | Tenax Therapeutics | 78.47 Mn | 78.47 Mn | - | -779,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -779,000.00 |
| Mar 31, 2026 | 21.19 Mn |
| Dec 31, 2025 | -1.80 Mn |
| Sep 30, 2025 | -6.09 Mn |
| Jun 30, 2025 | -5.99 Mn |
| Mar 31, 2025 | 16.60 Mn |
| Dec 31, 2024 | -3.46 Mn |
| Sep 30, 2024 | 88.93 Mn |
| Jun 30, 2024 | -3.17 Mn |
| Mar 31, 2024 | 2.76 Mn |
| Dec 31, 2023 | -1.35 Mn |
| Sep 30, 2023 | -2.25 Mn |
| Jun 30, 2023 | -1.02 Mn |
| Mar 31, 2023 | 12.29 Mn |
| Dec 31, 2022 | -1.68 Mn |
| Sep 30, 2022 | -3.42 Mn |
| Jun 30, 2022 | 4.36 Mn |
| Mar 31, 2022 | -2.72 Mn |
| Dec 31, 2021 | -2.77 Mn |
| Sep 30, 2021 | 6.68 Mn |